Comments Regarding Quantitative Labeling of Sodium, Potassium, and Phosphorus for OTC and Prescription Drug Products Share page: Docket Number: FDA-2021-D-0528 Download Document Issues: OTC Medicines Other Issues Labeling Quality Related Posts Articles Polibrief: Post-Consumer Recycled Content Jul 9, 2024 Press Releases and Statements CHPA Statement on U.S. Supreme Court Overturning the Chevron Standard Jun 28, 2024 Press Releases and Statements CHPA Welcomes New Board Members at June Meeting Jun 14, 2024